4967.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

Stats
Объем за сегодня	990 600
Средний объем	2.78M
Рыночная капитализация	412.06B
EPS	¥0 ( 2024-02-08 )
Дата следующего отчета о доходах	( ¥0 ) 2024-05-07
Last Dividend	¥39.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	20.66
ATR14	¥2.87 (0.05%)

Объем Корреляция

Длинно: -0.22 (neutral)

Кратко: 0.89 (strong)

Signal:(68.413) Same movement expected

Kobayashi Pharmaceutical Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Kobayashi Pharmaceutical Корреляция - Валюта/Сырье

0.15
( neutral )

-0.22
( neutral )

0.10
( neutral )

0.00
( neutral )

0.20
( neutral )

-0.19
( neutral )

Kobayashi Pharmaceutical Финансовые показатели

Annual	2023
Выручка:	¥173.46B
Валовая прибыль:	¥93.17B (53.72 %)
EPS:	¥268.16

FY	2023
Выручка:	¥173.46B
Валовая прибыль:	¥93.17B (53.72 %)
EPS:	¥268.16

FY	2022
Выручка:	¥166.26B
Валовая прибыль:	¥92.33B (55.53 %)
EPS:	¥259.61

FY	2021
Выручка:	¥155.25B
Валовая прибыль:	¥88.77B (57.18 %)
EPS:	¥187.94

Financial Reports:

No articles found.

Kobayashi Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥52.00 (N/A)	¥0 (N/A)	¥39.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Kobayashi Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.23 - Decrease likely (35.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.667	2001-03-27
Last Dividend	¥39.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	41	--
Total Paid Out	¥957.83	--
Avg. Dividend % Per Year	0.00%	--
Score	3.48	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.23
Div. Directional Score	6.90	--

Next Divdend (Est)
(2024-06-18)

¥0 Estimate 3.60 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.48

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3407.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2497.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9434.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8086.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7416.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6632.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
5958.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4659.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
3896.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3116.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.117	1.500	7.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0760	1.200	7.47	8.96	[0 - 0.3]
returnOnEquityTTM	0.0984	1.500	-0.0179	-0.0268	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.82	0.800	0.891	0.713	[1 - 3]
quickRatioTTM	2.37	0.800	0.782	0.625	[0.8 - 2.5]
cashRatioTTM	1.275	1.500	4.03	6.04	[0.2 - 2]
debtRatioTTM	0.00369	-1.500	9.94	-10.00	[0 - 0.6]
interestCoverageTTM	921.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00482	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.545	1.000	4.24	4.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.154	1.000	8.92	8.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	12.27	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.648	0.800	9.01	7.21	[0.5 - 2]
Total Score				10.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.45	1.000	8.04	0	[1 - 100]
returnOnEquityTTM	0.0984	2.50	-0.0115	-0.0268	[0.1 - 1.5]
freeCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.822	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0698	1.000	-0.754	0	[0.1 - 0.5]
Total Score				3.23

Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.